Exact Mass: 239.1456

Exact Mass Matches: 239.1456

Found 117 metabolites which its exact mass value is equals to given mass value 239.1456, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Salbutamol

4-Hydroxy-3-hydroxymethyl-alpha-((tert-butylamino)methyl)benzyl alcohol

C13H21NO3 (239.1521)


Salbutamol is a short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and COPD. It is 29 times more selective for beta2 receptors than beta1 receptors giving it higher specificity for pulmonary beta receptors versus beta1-adrenergic receptors located in the heart. Salbutamol is formulated as a racemic mixture of the R- and S-isomers. The R-isomer has 150 times greater affinity for the beta2-receptor than the S-isomer and the S-isomer has been associated with toxicity. This lead to the development of levalbuterol, the single R-isomer of salbutamol. However, the high cost of levalbuterol compared to salbutamol has deterred wide-spread use of this enantiomerically pure version of the drug. Salbutamol is generally used for acute episodes of bronchospasm caused by bronchial asthma, chronic bronchitis and other chronic bronchopulmonary disorders such as chronic obstructive pulmonary disorder (COPD). It is also used prophylactically for exercise-induced asthma Salbutamol or albuterol is a short-acting beta 2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma. -- Pubchem [HMDB] R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents Same as: D08124 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Salbutamol (Albuterol) is a short-acting beta-2 adrenergic receptor agonist with oral activity. Salbutamol promotes tumorigenesis of gastric cancer cells through the β2-AR/ERK/EMT pathway. Salbutamol is used to study bronchospasms caused by asthma and chronic obstructive pulmonary disease (COPD)[1][2]. Salbutamol (Albuterol) is a short-acting beta-2 adrenergic receptor agonist with oral activity. Salbutamol promotes tumorigenesis of gastric cancer cells through the β2-AR/ERK/EMT pathway. Salbutamol is used to study bronchospasms caused by asthma and chronic obstructive pulmonary disease (COPD)[1][2].

   

Isoetharine

4-{1-hydroxy-2-[(propan-2-yl)amino]butyl}benzene-1,2-diol

C13H21NO3 (239.1521)


Isoetharine is only found in individuals that have used or taken this drug. It is a selective adrenergic beta-2 agonist used as fast acting bronchodilator for emphysema, bronchitis and asthma. [PubChem]The pharmacologic effects of isoetharine are attributable to stimulation through beta-adrenergic receptors of intracellular adenyl cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic AMP. Increased cyclic AMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents

   

Macrophylline

Macrophylline

C13H21NO3 (239.1521)


   

Anatalline

3-(2-pyridin-3-ylpiperidin-4-yl)pyridine

C15H17N3 (239.1422)


   

6,8-Dimethyl-6,7-didehydroergoline

6,8-Dimethyl-6,7-didehydroergolin-6-ium

C16H19N2+ (239.1548)


   

Albuterol

Salbutamol

C13H21NO3 (239.1521)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; EAWAG_UCHEM_ID 2851 EAWAG_UCHEM_ID 2851; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 1100 Salbutamol (Albuterol) is a short-acting beta-2 adrenergic receptor agonist with oral activity. Salbutamol promotes tumorigenesis of gastric cancer cells through the β2-AR/ERK/EMT pathway. Salbutamol is used to study bronchospasms caused by asthma and chronic obstructive pulmonary disease (COPD)[1][2]. Salbutamol (Albuterol) is a short-acting beta-2 adrenergic receptor agonist with oral activity. Salbutamol promotes tumorigenesis of gastric cancer cells through the β2-AR/ERK/EMT pathway. Salbutamol is used to study bronchospasms caused by asthma and chronic obstructive pulmonary disease (COPD)[1][2].

   

Petasinine

[1-(hydroxymethyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-2-yl] (Z)-2-methylbut-2-enoate

C13H21NO3 (239.1521)


Petasinine is found in green vegetables. Petasinine is an alkaloid from Petasites japonicus (sweet coltsfoot

   

3alpha-Tigloyloxytropane N-oxide

8-Methyl-8-oxo-8λ⁵-azabicyclo[3.2.1]octan-3-yl (2E)-2-methylbut-2-enoic acid

C13H21NO3 (239.1521)


3alpha-Tigloyloxytropane N-oxide is found in fruits. 3alpha-Tigloyloxytropane N-oxide is an alkaloid from Physalis alkekengi (winter cherry). Alkaloid from Physalis alkekengi (winter cherry). 3alpha-Tigloyloxytropane N-oxide is found in fruits.

   

Moprolol

1-(2-methoxyphenoxy)-3-[(propan-2-yl)amino]propan-2-ol

C13H21NO3 (239.1521)


Moprolol is a beta-adrenergic antagonist, or beta blocker, typically prescribed to treat hypertension, high blood pressure, angina pectoris, arrhythmias, anxiety, and glaucoma. Moprolol was prominent in both literature and clinical trials up until the 1990s. At this point, moprolol was pulled from the market. This could have been for a number of reasons, including FDA recalls and ineffective formulations. Through some clinical trials, it was seen that moprolol was not as effective for treating blood pressure as originally thought (Wikipedia).

   

1,3-Di-o-tolylguanidine

1,3-Ditolylguanidine hydrochloride

C15H17N3 (239.1422)


D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

3'-Methyl-4-dimethylaminoazobenzene

Benzenamine,N,N-dimethyl-4-[2-(3-methylphenyl)diazenyl]-

C15H17N3 (239.1422)


   

3'-Methyl-dimethylaminoazobenzene

N,N,2-trimethyl-6-(2-phenyldiazen-1-yl)aniline

C15H17N3 (239.1422)


   

2-Methyl-4-(dimethylamino)azobenzene

N,N,3-trimethyl-4-(2-phenyldiazen-1-yl)aniline

C15H17N3 (239.1422)


   

3-(Imidazol-1-ylmethyl)-2-propan-2-yl-1H-indole

3-[(1H-imidazol-1-yl)methyl]-2-(propan-2-yl)-1H-indole

C15H17N3 (239.1422)


   
   

7-Angeloylturneforcidine

7-Angeloylturneforcidine

C13H21NO3 (239.1521)


   
   

Ditolylguanidine

1,3-Di-o-tolylguanidine

C15H17N3 (239.1422)


D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

Maybridge3_003022

Maybridge3_003022

C12H21N3S (239.1456)


   

DTXSID70965672

DTXSID70965672

C13H21NO3 (239.1521)


   

pandamarilactonine-G

pandamarilactonine-G

C13H21NO3 (239.1521)


   

(1S,3R,5S,6R)-6beta-hydroxy-3alpha-senecioyloxytropane|(3R,6R)-3alpha-hydroxy-6beta-seneciloyloxytropane|3alpha-Senecioyloxytropan-6beta-ol

(1S,3R,5S,6R)-6beta-hydroxy-3alpha-senecioyloxytropane|(3R,6R)-3alpha-hydroxy-6beta-seneciloyloxytropane|3alpha-Senecioyloxytropan-6beta-ol

C13H21NO3 (239.1521)


   

6beta-Tigloyloxy-3alpha-tropanol|6beta-tigloyloxytropan-3alpha-ol

6beta-Tigloyloxy-3alpha-tropanol|6beta-tigloyloxytropan-3alpha-ol

C13H21NO3 (239.1521)


   

noranabasamine

noranabasamine

C15H17N3 (239.1422)


   
   

O7-(3-Methylbutanoyl)retronecine

O7-(3-Methylbutanoyl)retronecine

C13H21NO3 (239.1521)


   

SCHEMBL19546086

SCHEMBL19546086

C13H21NO3 (239.1521)


   

(5E,7E)-3-acetamidoundeca-5,7-dienoic acid

NCGC00380408-01!(5E,7E)-3-acetamidoundeca-5,7-dienoic acid

C13H21NO3 (239.1521)


   

Salbutamol (Albuterol)

Salbutamol (Albuterol)

C13H21NO3 (239.1521)


   

Salbutamol

Salbutamol

C13H21NO3 (239.1521)


Salbutamol (Albuterol) is a short-acting beta-2 adrenergic receptor agonist with oral activity. Salbutamol promotes tumorigenesis of gastric cancer cells through the β2-AR/ERK/EMT pathway. Salbutamol is used to study bronchospasms caused by asthma and chronic obstructive pulmonary disease (COPD)[1][2]. Salbutamol (Albuterol) is a short-acting beta-2 adrenergic receptor agonist with oral activity. Salbutamol promotes tumorigenesis of gastric cancer cells through the β2-AR/ERK/EMT pathway. Salbutamol is used to study bronchospasms caused by asthma and chronic obstructive pulmonary disease (COPD)[1][2].

   

(5E,7E)-3-acetamidoundeca-5,7-dienoic acid_major

(5E,7E)-3-acetamidoundeca-5,7-dienoic acid_major

C13H21NO3 (239.1521)


   

(5E,7E)-3-acetamidoundeca-5,7-dienoic acid_12.9\\%

(5E,7E)-3-acetamidoundeca-5,7-dienoic acid_12.9\\%

C13H21NO3 (239.1521)


   

(5E,7E)-3-acetamidoundeca-5,7-dienoic acid_16.1\\%

(5E,7E)-3-acetamidoundeca-5,7-dienoic acid_16.1\\%

C13H21NO3 (239.1521)


   

(5E,7E)-3-acetamidoundeca-5,7-dienoic acid

(5E,7E)-3-acetamidoundeca-5,7-dienoic acid

C13H21NO3 (239.1521)


   

Pyridylnicotine

Pyridylnicotine

C15H17N3 (239.1422)


   

Petasinine

1-(hydroxymethyl)-hexahydro-1H-pyrrolizin-2-yl 2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

3a-Tigloyloxytropane N-oxide

8-methyl-8-oxo-8$l^{5}-azabicyclo[3.2.1]octan-3-yl (2E)-2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

(5E,7E)-3-Acetamido-5,7-undecadienoic acid

(5E,7E)-3-Acetamido-5,7-undecadienoic acid

C13H21NO3 (239.1521)


   

tert-butyl 2-oxo-6-azaspiro[3.5]nonane-6-carboxylate

tert-butyl 2-oxo-6-azaspiro[3.5]nonane-6-carboxylate

C13H21NO3 (239.1521)


   

4-oxo-4-[(3,3,5-trimethylcyclohexyl)amino]but-2-enoic acid

4-oxo-4-[(3,3,5-trimethylcyclohexyl)amino]but-2-enoic acid

C13H21NO3 (239.1521)


   

2-[2-(3-hydroxypropylamino)ethylidene]-5,5-dimethylcyclohexane-1,3-dione

2-[2-(3-hydroxypropylamino)ethylidene]-5,5-dimethylcyclohexane-1,3-dione

C13H21NO3 (239.1521)


   
   

4-dimethylamino-4-methylazobenzene

4-dimethylamino-4-methylazobenzene

C15H17N3 (239.1422)


   

tert-butyl 3-(2H-tetrazol-5-yl)pyrrolidine-1-carboxylate

tert-butyl 3-(2H-tetrazol-5-yl)pyrrolidine-1-carboxylate

C10H17N5O2 (239.1382)


   

1-[4-(hydroxymethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol

1-[4-(hydroxymethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol

C13H21NO3 (239.1521)


   

cis-N-benzyl-4-methylcyclohexan-1-amine

cis-N-benzyl-4-methylcyclohexan-1-amine

C14H22ClN (239.1441)


   

6-Benzyl-5,6,7,8-tetrahydro-1,6-naphthyridin-3-amine

6-Benzyl-5,6,7,8-tetrahydro-1,6-naphthyridin-3-amine

C15H17N3 (239.1422)


   

tert-Butyl 4-oxooctahydro-1H-indole-1-carboxylate

tert-Butyl 4-oxooctahydro-1H-indole-1-carboxylate

C13H21NO3 (239.1521)


   

(8-NITRO-IMIDAZO[1,2-A]PYRIDIN-2-YL)-ACETICACID

(8-NITRO-IMIDAZO[1,2-A]PYRIDIN-2-YL)-ACETICACID

C15H17N3 (239.1422)


   

4-(3-PHENYL-PROPYL)-PIPERIDINE HCL

4-(3-PHENYL-PROPYL)-PIPERIDINE HCL

C14H22ClN (239.1441)


   

tert-butyl 1-oxo-7-azaspiro[3.5]nonane-7-carboxylate

tert-butyl 1-oxo-7-azaspiro[3.5]nonane-7-carboxylate

C13H21NO3 (239.1521)


   

1-(4-ethoxy-3,5-dimethoxyphenyl)propan-2-amine

1-(4-ethoxy-3,5-dimethoxyphenyl)propan-2-amine

C13H21NO3 (239.1521)


   

(3AR,7AS)-REL-TERT-BUTYL 5-OXOOCTAHYDRO-1H-INDOLE-1-CARBOXYLATE

(3AR,7AS)-REL-TERT-BUTYL 5-OXOOCTAHYDRO-1H-INDOLE-1-CARBOXYLATE

C13H21NO3 (239.1521)


   

2-((3,4-dimethoxyphenethyl)(Methyl)amino)ethanol

2-((3,4-dimethoxyphenethyl)(Methyl)amino)ethanol

C13H21NO3 (239.1521)


   

Benzenamine,N,N-dimethyl-4-[2-(2-methylphenyl)diazenyl]-

Benzenamine,N,N-dimethyl-4-[2-(2-methylphenyl)diazenyl]-

C15H17N3 (239.1422)


   

2-[bis(2-hydroxyethyl)amino]ethanol,2-hydroxypropanoic acid

2-[bis(2-hydroxyethyl)amino]ethanol,2-hydroxypropanoic acid

C9H21NO6 (239.1369)


   

4-(2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-4-yl)aniline

4-(2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-4-yl)aniline

C15H17N3 (239.1422)


   

3-(2-cyclohexylethyl)-4-ethyl-1H-1,2,4-triazole-5-thione

3-(2-cyclohexylethyl)-4-ethyl-1H-1,2,4-triazole-5-thione

C12H21N3S (239.1456)


   

Benzenemethanamine,N-cyclohexyl-a-methyl-,hydrochloride (1:1)

Benzenemethanamine,N-cyclohexyl-a-methyl-,hydrochloride (1:1)

C14H22ClN (239.1441)


   

3METHYL4DIMETHYLAMINOAZOBENZENE(3-METHYLISOMER)

3METHYL4DIMETHYLAMINOAZOBENZENE(3-METHYLISOMER)

C15H17N3 (239.1422)


   

4-(2-Methylpropoxy)benzenemethanamine acetate

4-(2-Methylpropoxy)benzenemethanamine acetate

C11H17NO.C2H4O2 (239.1521)


   

(2,4-DIMETHYL-PHENYL)-PHOSPHONICACIDDIETHYLESTER

(2,4-DIMETHYL-PHENYL)-PHOSPHONICACIDDIETHYLESTER

C13H21NO3 (239.1521)


   

tert-butyl 4-oxo-octahydroindole-1-carboxylate

tert-butyl 4-oxo-octahydroindole-1-carboxylate

C13H21NO3 (239.1521)


   

N-Boc-9-Azabicyclo[3.3.1]nonan-3-one

N-Boc-9-Azabicyclo[3.3.1]nonan-3-one

C13H21NO3 (239.1521)


   

11-amino-1-undecanethiol

11-amino-1-undecanethiol

C11H26ClNS (239.1474)


   

1-benzyl-4-cyanomethyl-piperidine-4-carbonitrile

1-benzyl-4-cyanomethyl-piperidine-4-carbonitrile

C15H17N3 (239.1422)


   

Levomoprolol

(S)-1-(ISOPROPYLAMINO)-3-(2-METHOXYPHENOXY)PROPAN-2-OL

C13H21NO3 (239.1521)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist

   

Levalbuterol

(-)-Salbutamol

C13H21NO3 (239.1521)


C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist Same as: D08124

   

4-[4-(Dimethylamino)styryl]-n-methylpyridinium

4-[4-(Dimethylamino)styryl]-n-methylpyridinium

C16H19N2+ (239.1548)


   

2-[4-(Dimethylamino)styryl]-1-methylpyridinium

2-[4-(Dimethylamino)styryl]-1-methylpyridinium

C16H19N2+ (239.1548)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D004396 - Coloring Agents > D005456 - Fluorescent Dyes D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

   

Agroclavine(1+)

Agroclavine(1+)

C16H19N2+ (239.1548)


An ammonium ion resulting from the protonation of the tertiary amino group of agroclavine. The major species at pH 7.3.

   

Moprolol

1-(ISOPROPYLAMINO)-3-(2-METHOXYPHENOXY)PROPAN-2-OL

C13H21NO3 (239.1521)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist

   

isoetarine

isoetharine

C13H21NO3 (239.1521)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents

   

6,8-Dimethyl-6,7-didehydroergolin-6-ium

6,8-Dimethyl-6,7-didehydroergolin-6-ium

C16H19N2+ (239.1548)


A cationic ergot alkaloid that is the 6,8-dimethyl-6,7-didehydro derivative of ergoline.

   

3-Methyl-4-dimethylaminoazobenzene

Benzenamine,N,N-dimethyl-4-[2-(3-methylphenyl)diazenyl]-

C15H17N3 (239.1422)


   

3alpha-Tigloyloxytropane N-oxide

3alpha-Tigloyloxytropane N-oxide

C13H21NO3 (239.1521)


   

(1r,5r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

(1r,5r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

1-{4-[(2r,4r)-4-methyl-5-oxooxolan-2-yl]butyl}pyrrolidin-2-one

1-{4-[(2r,4r)-4-methyl-5-oxooxolan-2-yl]butyl}pyrrolidin-2-one

C13H21NO3 (239.1521)


   

(1s,3s,5r,6s)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl (2z)-2-methylbut-2-enoate

(1s,3s,5r,6s)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl (2z)-2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

n-[2-(dimethylamino)-4-methoxy-6-(methylamino)pyrimidin-5-yl]-n-methylformamide

n-[2-(dimethylamino)-4-methoxy-6-(methylamino)pyrimidin-5-yl]-n-methylformamide

C10H17N5O2 (239.1382)


   

(1r,3s,5r,6s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-methylbut-2-enoate

(1r,3s,5r,6s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-methylbut-2-enoate

C13H21NO3 (239.1521)


   

(1r,3r,5s,6r)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl (2z)-2-methylbut-2-enoate

(1r,3r,5s,6r)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl (2z)-2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

[(1s,7r)-7-hydroxy-hexahydro-1h-pyrrolizin-1-yl]methyl (2e)-2-methylbut-2-enoate

[(1s,7r)-7-hydroxy-hexahydro-1h-pyrrolizin-1-yl]methyl (2e)-2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

7-(hydroxymethyl)-hexahydro-1h-pyrrolizin-1-yl 2-methylbut-2-enoate

7-(hydroxymethyl)-hexahydro-1h-pyrrolizin-1-yl 2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

(1r,2s,7as)-1-(hydroxymethyl)-hexahydro-1h-pyrrolizin-2-yl 3-methylbut-2-enoate

(1r,2s,7as)-1-(hydroxymethyl)-hexahydro-1h-pyrrolizin-2-yl 3-methylbut-2-enoate

C13H21NO3 (239.1521)


   

(1r,3s,5s,6r)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl (2e)-2-methylbut-2-enoate

(1r,3s,5s,6r)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl (2e)-2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

(1r,3r,5s,6r)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl 3-methylbut-2-enoate

(1r,3r,5s,6r)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl 3-methylbut-2-enoate

C13H21NO3 (239.1521)


   

(1r,7s,7ar)-7-(hydroxymethyl)-hexahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

(1r,7s,7ar)-7-(hydroxymethyl)-hexahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

dimethyl[2-(3,4,5-trimethoxyphenyl)ethyl]amine

dimethyl[2-(3,4,5-trimethoxyphenyl)ethyl]amine

C13H21NO3 (239.1521)


   

[(1r,7r,7ar)-7-hydroxy-hexahydro-1h-pyrrolizin-1-yl]methyl (2z)-2-methylbut-2-enoate

[(1r,7r,7ar)-7-hydroxy-hexahydro-1h-pyrrolizin-1-yl]methyl (2z)-2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

(1s,3s,5r,6s)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl (2e)-2-methylbut-2-enoate

(1s,3s,5r,6s)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl (2e)-2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

(1r,7s)-7-(hydroxymethyl)-hexahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

(1r,7s)-7-(hydroxymethyl)-hexahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

[(1s,7r)-7-hydroxy-hexahydro-1h-pyrrolizin-1-yl]methyl (2z)-2-methylbut-2-enoate

[(1s,7r)-7-hydroxy-hexahydro-1h-pyrrolizin-1-yl]methyl (2z)-2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl 3-methylbut-2-enoate

3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl 3-methylbut-2-enoate

C13H21NO3 (239.1521)


   

3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl 2-methylbut-2-enoate

3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl 2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

[(1s,7r,7as)-7-hydroxy-hexahydro-1h-pyrrolizin-1-yl]methyl (2z)-2-methylbut-2-enoate

[(1s,7r,7as)-7-hydroxy-hexahydro-1h-pyrrolizin-1-yl]methyl (2z)-2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

(1s,3r,5s,6r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-methylbut-2-enoate

(1s,3r,5s,6r)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-methylbut-2-enoate

C13H21NO3 (239.1521)


   

(1s,7ar)-7-(hydroxymethyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2r)-2-methylbutanoate

(1s,7ar)-7-(hydroxymethyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2r)-2-methylbutanoate

C13H21NO3 (239.1521)


   

(1r,7r,7ar)-7-(hydroxymethyl)-hexahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

(1r,7r,7ar)-7-(hydroxymethyl)-hexahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

(1r)-7-(hydroxymethyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 2-methylbutanoate

(1r)-7-(hydroxymethyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 2-methylbutanoate

C13H21NO3 (239.1521)


   

(1s,5r)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl (2e)-2-methylbut-2-enoate

(1s,5r)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl (2e)-2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

7-(hydroxymethyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 2-methylbutanoate

7-(hydroxymethyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 2-methylbutanoate

C13H21NO3 (239.1521)


   

1-[4-(4-methyl-5-oxooxolan-2-yl)butyl]pyrrolidin-2-one

1-[4-(4-methyl-5-oxooxolan-2-yl)butyl]pyrrolidin-2-one

C13H21NO3 (239.1521)


   

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-methylbut-2-enoate

6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-methylbut-2-enoate

C13H21NO3 (239.1521)


   

(7-hydroxy-hexahydro-1h-pyrrolizin-1-yl)methyl 2-methylbut-2-enoate

(7-hydroxy-hexahydro-1h-pyrrolizin-1-yl)methyl 2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

3-[(2r,4r)-2-(pyridin-3-yl)piperidin-4-yl]pyridine

3-[(2r,4r)-2-(pyridin-3-yl)piperidin-4-yl]pyridine

C15H17N3 (239.1422)


   

1-(hydroxymethyl)-hexahydro-1h-pyrrolizin-2-yl 3-methylbut-2-enoate

1-(hydroxymethyl)-hexahydro-1h-pyrrolizin-2-yl 3-methylbut-2-enoate

C13H21NO3 (239.1521)


   

(2-hydroxy-hexahydro-1h-pyrrolizin-1-yl)methyl 3-methylbut-2-enoate

(2-hydroxy-hexahydro-1h-pyrrolizin-1-yl)methyl 3-methylbut-2-enoate

C13H21NO3 (239.1521)


   

3-[2-(pyridin-3-yl)piperidin-4-yl]pyridine

3-[2-(pyridin-3-yl)piperidin-4-yl]pyridine

C15H17N3 (239.1422)


   

[(1s,7s,7ar)-7-hydroxy-hexahydro-1h-pyrrolizin-1-yl]methyl (2z)-2-methylbut-2-enoate

[(1s,7s,7ar)-7-hydroxy-hexahydro-1h-pyrrolizin-1-yl]methyl (2z)-2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

[(1s,7s,7as)-7-hydroxy-hexahydro-1h-pyrrolizin-1-yl]methyl (2z)-2-methylbut-2-enoate

[(1s,7s,7as)-7-hydroxy-hexahydro-1h-pyrrolizin-1-yl]methyl (2z)-2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

[(1s,7r,7ar)-7-hydroxy-hexahydro-1h-pyrrolizin-1-yl]methyl (2z)-2-methylbut-2-enoate

[(1s,7r,7ar)-7-hydroxy-hexahydro-1h-pyrrolizin-1-yl]methyl (2z)-2-methylbut-2-enoate

C13H21NO3 (239.1521)


   

[(1r,2s,7as)-2-hydroxy-hexahydro-1h-pyrrolizin-1-yl]methyl 3-methylbut-2-enoate

[(1r,2s,7as)-2-hydroxy-hexahydro-1h-pyrrolizin-1-yl]methyl 3-methylbut-2-enoate

C13H21NO3 (239.1521)


   

3-[(2r,4s)-2-(pyridin-3-yl)piperidin-4-yl]pyridine

3-[(2r,4s)-2-(pyridin-3-yl)piperidin-4-yl]pyridine

C15H17N3 (239.1422)


   

(1s,7s,7ar)-7-(hydroxymethyl)-hexahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

(1s,7s,7ar)-7-(hydroxymethyl)-hexahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

C13H21NO3 (239.1521)